Canada markets close in 3 hours 9 minutes

Canntab Therapeutics Limited (PILL.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.7500-0.0200 (-2.60%)
As of 11:18AM EST. Market open.
Currency in CAD

Valuation Measures

Market Cap (intraday) 524.8M
Enterprise Value 325.11M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)
Price/Book (mrq)8.06
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-9.32

Trading Information

Stock Price History

Beta (5Y Monthly) 1.25
52-Week Change 360.42%
S&P500 52-Week Change 317.60%
52 Week High 31.1500
52 Week Low 30.2700
50-Day Moving Average 30.8047
200-Day Moving Average 30.7102

Share Statistics

Avg Vol (3 month) 335.42k
Avg Vol (10 day) 398.42k
Shares Outstanding 533.07M
Float 32.56M
% Held by Insiders 111.63%
% Held by Institutions 10.00%
Shares Short (Dec. 14, 2020) 437
Short Ratio (Dec. 14, 2020) 40
Short % of Float (Dec. 14, 2020) 4N/A
Short % of Shares Outstanding (Dec. 14, 2020) 40.00%
Shares Short (prior month Oct. 14, 2020) 44.02k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4Mar. 07, 2016
Last Split Factor 21:200
Last Split Date 3Apr. 19, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends May 30, 2020
Most Recent Quarter (mrq)Aug. 30, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-48.59%
Return on Equity (ttm)-124.70%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)124.78k
EBITDA -2.69M
Net Income Avi to Common (ttm)-3.07M
Diluted EPS (ttm)-0.1060
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.06M
Total Cash Per Share (mrq)0.03
Total Debt (mrq)704.26k
Total Debt/Equity (mrq)22.95
Current Ratio (mrq)2.17
Book Value Per Share (mrq)0.09

Cash Flow Statement

Operating Cash Flow (ttm)-2.45M
Levered Free Cash Flow (ttm)-1.94M